Home Compliance Pushing Back on Kickbacks: $900 Million Settlement in Biotech False Claims Act... ComplianceExpert OpinionFCANews Pushing Back on Kickbacks: $900 Million Settlement in Biotech False Claims Act Case August 1, 2022 17 Share FacebookLinkedinTwitter Africa Studio | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance CFIUS Proposes Important Changes to Foreign Investment Rules with Focus on Enforcement Compliance Start Here: Cyber Fundamentals for Public Policy Makers Episodes 4-6 Compliance Second Circuit Defines “Willfulness” Standard Under Anti-Kickback Statute